GENE ONLINE|News &
Opinion
Blog

Hong Kong
BIOHK2023: A Place Where Biotechnology Meets Financial Economics
2023-09-21
2023 International Healthcare Week: Showcasing Emerging Competencies of Hong Kong’s Biomedical Industry
2023-06-05
CK Life Sciences and CK Hutchison Invest in Taiwanese Liquid Biopsy Candidate
2022-07-26
Quion Licenses Two Rare Skin Disease Candidates to Hong Kong WinHealth
2022-06-16
UMP Healthcare Expands Free Telemedicine and Drug Delivery to COVID-19 Patients
2022-03-31
Bavarian Nordic Establishes Asia Link for Its RSV Vaccines
2022-03-24
Fifth Wave of COVID-19 Devastates Hong Kong – How Next-Generation Sequencing Can Help with Latest Outbreak
2022-03-08Partner
How Our Microbiomes Are Connected to Irritable Bowel Syndromes, Cancer and Autism: Highlights from the 6th Asia Microbiome Conference
2022-02-14
Scientists Work On an Oral Vaccine Booster for COVID-19
2022-01-07
GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021
2022-01-07
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
CStone Wins Hong Kong Approval for Gastrointestinal Tumor Drug
2021-12-29
Experts Discuss What’s Next for Healthcare Innovation and Investment at ASGH
2021-12-02
Could this Biotech be the First Billion-Dollar Hong Kong Startup to Go Public?
2021-07-18
Lifebit Provides BioMedical ICT Solution for Hong Kong’s Large-Scale Genome Sequencing Project
2021-05-27
1 2
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top